• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Yue, SUN Chunmeng, TU Jiasheng. Research progress on compatibility between pharmaceutical injections and plastic packaging materials[J]. Journal of China Pharmaceutical University, 2020, 51(1): 19-23. DOI: 10.11665/j.issn.1000-5048.20200103
Citation: ZHANG Yue, SUN Chunmeng, TU Jiasheng. Research progress on compatibility between pharmaceutical injections and plastic packaging materials[J]. Journal of China Pharmaceutical University, 2020, 51(1): 19-23. DOI: 10.11665/j.issn.1000-5048.20200103

Research progress on compatibility between pharmaceutical injections and plastic packaging materials

More Information
  • Taking plastic packaging materials as an example, this paper mainly summarizes the general principles of pharmacopoeias and guiding principles of relevant government departments related to the compatibility studies of drugs and packaging materials at home and abroad, with much reference to relevant monographs and literature. The purpose and specific methods of extraction and interaction studies are summarized and discussed. The existing problems and solutions in compatibility research are also proposed in this review to provide some refe-rence for researchers in relevant fields.
  • [1]
    Jin GY,Wang CM,Mo QP.Simultaneous determination of 5 kinds of antioxygens in drug plastic packaging materials by HPLC[J].Chin Med Pharm(中国医药科学),2018,8(17):62-65.
    [2]
    Zhang WH.Study on compatibility of new type compound amino acids injection and packaging materials(新型复方氨基酸注射液的内包装材料相容性研究)[D].Beijing University of Chemical Technology,2016.
    [3]
    Zhang Y,Yuan Q,Jiang M,et al.Research progress in toxicity and detection methods of phthalic acid esters[J].Environ Chem(环境化学),2019,38(5):1035-1046.
    [4]
    U.S.Food and Drug Administration.Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products[EB/OL].[2012-12-21] .https://www.fda.gov/media/83029/download.
    [5]
    China Food and Drug Administration.YBB00142002 Guideline of Evaluating Compatibility between Pharmaceutical Packaging and Pharmaceuticals(药品包装材料与药物相容性试验指导原则)[S].2002:72-74.
    [6]
    China Food and Drug Administration.Regulations on immediate package materials an containers of drugs.(直接接触药品的包装材料和容器管理办法)[EB/OL].[2004-07-20] .http://www.sda.gov.cn/WS01/CL0053/24499.html.
    [7]
    China Food and Drug Administraion.Technical Guidelines for the Research on the Compatibility of Chemical Medicine Injection and Glass Packing Container(化学药品注射剂与药用玻璃包装容器相容性研究技术指导原则)[S].2015.
    [8]
    Chinese Pharmacopoeia Commission.Chinese Phamacopeia:part 4(中华人民共和国药典:四部)[S].Beijing:China Medical Science Press,2015:413-416.
    [9]
    U.S.Food and Drug Administration.Guidance for industry.container closure systems for packaging human drugs and biologics[EB/OL].[1999-05-01] .http:/www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ UCM070551.pdf.
    [10]
    United States Pharmacopeia Convention.United States Pharmacopoeia 40[S].United States Pharmacopeia Convention,2017:541-554.
    [11]
    European Medicines Agency.Guideline on plastic immediate packaging materials[EB/OL].[2005-05-19] .http://www.ema.europa.eu/docs/en_GB/document_library/Scientific _ guideline/2009/09/WC500003448.pdf.
    [12]
    European Directorate for the Quality of Medicines.European Pharmacopoeia 9.0[S].European Directorate for the Quality of Medicines & Health Care,2017:390-430.
    [13]
    Pharmaceuticals and Medical Devices Agency.The Japanese Pharmacopoeia 17[S].Ministry of Health,Labour and Welfare,2016:166-179.
    [14]
    Jenke D,Odufu A,Poss M.The effect of solvent polarity on the accumulation of leachables from pharmaceutical product containers[J].Eur J Pharm Sci,2006,27(2/3):133-142.
    [15]
    Jenke DR,Story J,Lalani R.Extractables/leachables from plastic tubing used in product manufacturing[J].Int J Pharm,2006,315(1/2):75-92.
    [16]
    Jenke DR,Stults CL,Paskiet DM,et al.Materials in manufacturing and packaging systems as sources of elemental impurities in packaged drug products:a literature review[J].PDA J Pharm Sci Technol,2015,69(1):1-48.
    [17]
    Green S,Bai S,Cheatham M,et al.Determination of antioxidants in polyolefins using total dissolution methodology followed by RPLC[J].J Sep Sci,2010,33(22):3455-3462.
    [18]
    Stults CL,Ansell JM,Shaw AJ,et al.Evaluation of extractables in processed and unprocessed polymer materials used for pharmaceutical applications[J].AAPS Pharmscitech,2015,16(1):150-164.
    [19]
    Gao Y,Allison N.Extractables and leachables issues with the application of single use technology in the biopharmaceutical industry[J].J Chem Technol Biot,2016,91(2):289-295.
    [20]
    Lin HJ,Wu Y,Zhang YL.Extraction and determination of DBP degradated from Irgafos 168 in three-layer co-extrusion film for infusion bag[J].Chin J Pharm(中国医药工业杂志),2014,45(7):677-680.
    [21]
    Li Y,Sun HM,Zhang X.Determination of antioxidants in plastic infusion packaging materials and containers and the migration to injections[J].Chin Pharm J(中国药学杂志),2016,51(19):1699-1705.
    [22]
    Wang F, Li Y, Sun HM. Migration studies on the additives of polypropylene infusion bottle[J].Chin J Pharm Anal(药物分析杂志),2012,32(3):414-415.
    [23]
    Liu QP.Research of ambroxol hydrochloride glucose infusion packed by multi-layer co-extruded injection film(多层共挤膜输液袋盐酸氨溴索葡萄糖注射液的研究)[D].Tianjin University,2016.
    [24]
    Zhao X, He X, Sun HM. Study on the migration of residual styrene to injection from three-layer co-extrusion bags[J].Chin Pharm Aff(中国药事),2014,28(8):835-838.
    [25]
    Liu XH,Yin H,Yan F,et al.Compatibility of pre-filled syringes with pharmaceutical products[J].J China Pharm Univ(中国药科大学),2016,47(3):275-281.
    [26]
    Bao Y,Geng Z,Yuan WX,et al.Adsorption of urapidil by urapidil injection and urapidil hydrochloride injection packaging materials[J].Pharm J Chin PLA(解放军药学学报),2017,33(5):448-450.
  • Related Articles

    [1]HOU Yurong, FAN Qingfeng, SHI Sunliang, YUAN Yaozuo, ZHANG Mei. Determination of the content of sisomicin sulfate and sodium chloride injection by RP-HPLC[J]. Journal of China Pharmaceutical University, 2018, 49(6): 695-698. DOI: 10.11665/j.issn.1000-5048.20180609
    [2]YAN Zhengyu, SHU Juan, YU Yan, ZHANG Zhengwei, TANG Lu, CHEN Jianqiu. Preparation and application of carbon dots in chloramphenicol determination[J]. Journal of China Pharmaceutical University, 2015, 46(3): 322-327. DOI: 10.11665/j.issn.1000-5048.20150310
    [3]ZHONG Wen-ying, HUANG Bin, CHEN Lin, SHU Chang. Fluorescence resonance energy transfer quenching for determination of vitamin B2[J]. Journal of China Pharmaceutical University, 2011, 42(6): 527-533.
    [4]Determination of Cyclosporin A in Ocular Tissues by HPLC-MS[J]. Journal of China Pharmaceutical University, 2003, (4): 44-47.
    [5]Content Determination and Stability Research on Diclofenac-Zn[J]. Journal of China Pharmaceutical University, 2002, (3): 92-93.
    [6]Determination of Contents of Dextromethorphan Hydrobromide and Guaifenesine in Capsules by HPLC[J]. Journal of China Pharmaceutical University, 1999, (5): 367-369.
    [7]Determination of Norgestrel in Compound Preparation by First Derivative Spectrography[J]. Journal of China Pharmaceutical University, 1995, (4): 246-247.
    [8]HPLC Determination of Diclofenac in Transdermal Receiver Solution[J]. Journal of China Pharmaceutical University, 1994, (6): 342-344.
    [9]A Reversed-Phase HPLC Method for the Determination of Paeoniflorin Content[J]. Journal of China Pharmaceutical University, 1994, (4): 46-48.
    [10]Study on the Content of Tetrahydropalmatine in Corydalis Yanhusuo by SLS-micellar Enhanced Fluorometry[J]. Journal of China Pharmaceutical University, 1993, (6): 345-347.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return